29 May 2026
There's one mistake I keep seeing in healthcare IT outsourcing. A team starts from the belief that their case is unique, so the safest move is to build almost everything from scratch. New architecture, new integrations, their own reading of the standards, a custom take on patient data privacy, their own path through regulation. Sounds responsible. In practice, it usually means paying full price for problems the market solved years ago.
And that's the strange thing about healthcare as a category. From the outside it looks advanced, specialised, full of edge cases. And it is. But most of the real difficulty doesn't come from anything glamorous. It comes from repetitive complexity. Different organisations keep running into the same structural problems — patient identity, document exchange, e-prescriptions, audit trails, mobile data permissions, the next regulatory update — and keep treating each one like a fresh engineering discovery. A bit like rediscovering seatbelts every few years and being proud of yourself each time. That's where most of the money disappears.
Healthcare software outsourcing is really about buying institutional memory
This matters more than it used to, because healthtech stopped being a collection of separate apps. It's now a system where one thing pulls another along — national platforms, hospital systems, telemedicine providers and consumer health apps all end up referencing each other. In Europe the national infrastructure is maturing fast, and Poland is a good example.
The European Commission's 2025 eHealth Indicator Study put the EU-27 average maturity at 83%, while Poland reached 92%, which placed it among the top performers. By October 2025 more than 20 million people had activated their Internetowe Konto Pacjenta, and the system had handled 2.8 billion e-prescriptions, nearly 298 million e-referrals and 1.42 billion recorded medical events. At that scale you're not building a neat standalone product anymore. You're plugging into infrastructure that's already enormous, already regulated, and already moving without you.
That's the first real benefit of working with specialists. You're not buying extra hands. You're buying memory and healthcare domain expertise. A team that has already shipped P1 integrations, handled serious patient portal development, wrestled with EDM indexing, reported medical events and mapped clinical data into something interoperable doesn't start the project with curiosity. It starts with reflexes. The most expensive delays in healthcare projects almost never come from writing code. They come from the moment, three sprints in, when somebody realises that "small requirement" in the brief was actually a separate platform — or that an early architectural decision just locked the product into the wrong shape for the next four years.
Beyond the standards diagram
The clearest example is interoperability. For years medical data lived in silos, scattered across electronic health records and proprietary databases, and every integration felt like running cables through concrete. HL7 FHIR changed that by treating medical data as ordinary web resources you can call, query and transform. The shift was a bit like going from fax machines — where to share a result you had to print it, sign it, fax it back — to email with attachments. Or from buying albums on CD to streaming. Same data, suddenly liquid.
A FHIR-literate partner doesn't just know what FHIR is. They know when to stay conservative on R4 (still the pragmatic baseline, partly because parts of it are normative and partly because R5 adoption is thin and R6 is coming), when newer patterns are worth the cost, where national requirements override generic assumptions, and how to keep "modern interoperability" from turning into a version zoo. They also know that in real hospitals the elegant architecture diagram is only half the story. The other half is whatever the existing HIS in the basement, the local registration habits, and whoever won the last tender will let you actually get away with. Internal teams sometimes assume their own constraints are universal. People who've seen ten different setups can usually tell the difference between a real limitation and a vendor habit nobody questioned in eight years.
What Poland's P1 actually teaches you
The Polish market shows this almost too clearly. P1 has been rolling out in waves for years: e-prescriptions became mandatory nationwide on 8 January 2020, e-referrals followed in January 2021, and central e-registration is now in production. As of January 2026 it's mandatory for mammography, cervical screening and first cardiology visits — and the early numbers are real, not a press release: more than 84,000 visits booked through IKP in the first week alone, 186,000 in the first two. Providers have until 1 July 2026 to integrate, and from June the NFZ stops paying clinics that haven't connected. By 2029 the goal is for central e-registration to cover essentially the whole publicly funded system.
That means the local calendar, the HIS, the patient engagement platform sitting on top of it and the national platform have to stop pretending they're separate worlds. A team that has already lived through one or two of these waves doesn't panic when the next one lands on a Friday at 4pm. They've seen this Friday before.
The mobile platforms are moving the floor
The mobile layer makes the whole thing harder, because Apple and Google are changing the rules underneath health apps faster than most healthcare organisations track. Google has deprecated the Google Fit APIs, with end-of-service scheduled for late 2026, and is steering developers toward Health Connect for mobile-first apps and Google Health API for cloud-based ones. That's not just rebranding — it changes the storage model, the integration path and, for many products, the compliance and healthcare data security story. Google Play has tightened the policy side too: stronger Health Connect safeguards, clearer justification required for access to sensitive health record data, and a dedicated declaration for health and medical apps.
Apple goes the opposite direction. HealthKit keeps the data on the device, splits read and write permissions, demands explicit user consent, and stores everything under strong device protection — Apple acts like a Swiss safe, where the keys belong to the owner and every drawer needs its own permission. Android under Health Connect feels more like a modern bank: data can move, but every movement is wrapped in policy. Both philosophies make sense. The catch is that one product often has to live in both.
The regulation isn't background noise anymore
And then there's regulation, which used to be a thing you handed to legal at the end. The European Health Data Space entered into force on 26 March 2025 and sets out a phased path toward cross-border primary use and tightly governed secondary use of health data for research and healthcare analytics, with key application milestones in 2029 and 2031. The AI Act came in on 1 August 2024, prohibited practices started applying in February 2025, GPAI obligations in August 2025, and the rules for high-risk AI built into regulated products — including medical device software and clinical decision support — apply from 2 August 2027.
The practical meaning is hard to overstate. Auditability and explainability used to be quality-team concerns. Now they're legal-team concerns, because without them a product simply can't ship. Think of it as homologation for software. You can build the most beautiful car in the world, but if you don't have the right paperwork, you don't drive it off the lot.
What outsourcing healthcare IT is actually buying
This is where the argument stops being mainly about cost, even though cost is still part of it. If you try to keep all of this fully in-house, you don't just need a few engineers. You need somebody watching FHIR, somebody watching CeZ announcements, somebody watching Apple, somebody watching Google, somebody watching the EHDS implementing acts, somebody watching the AI Act guidance — every day. That's not a hire. That's a small in-house watchdesk you have to keep alive forever, even when nothing's happening, because the moment you let it go quiet is the moment something breaks.
Some organisations genuinely need that watchdesk and should build it. Most don't need it at full strength every day, but absolutely need to plug into one at the right moments and at the right depth.
That's why the best thing a specialist partner gives you isn't speed. It's a calmer Friday afternoon. The kind where CeZ announces at 4pm that a message format is changing on Monday, and somebody, somewhere, already saw it coming, already did the rewrite, and already knows where to click. Healthcare software used to be about building tools. Now it's about staying alive inside a system that is more connected, more audited and less forgiving every year. In that environment, to outsource healthcare software development isn't a shortcut around complexity. It's one of the few realistic ways to stop paying for the same complexity twice.
Conclusion
It's worth saying out loud: outsourcing is not always the right call. You can lose internal domain knowledge, end up locked into a vendor, and create continuity risk around something as serious as patient data. Anyone who tells you otherwise is selling you something. The reason a good specialist partner matters is precisely because these risks are real. A bad partner amplifies all three. A good one stays explicit about the handover, documents what they do, and treats the client's internal team as the long-term owner — not as a customer to keep dependent.
If a partner can't answer the question "what happens if we walk away in eighteen months" without flinching, that's the answer.
Top AI innovations delivered monthly!
The administrator of your personal data is Miquido sp. z o.o. sp.k., with its ... registered office in Kraków at Zabłocie 43A, 30 - 701. We process the provided information in order to send you a newsletter. The basis for processing of your data is your consent and Miquido’s legitimate interest.You may withdraw your consent at any time by contacting us at marketing@miquido.com. You have the right to object, the right to access your data, the right to request rectification, deletion or restriction of data processing. For detailed information on the processing of your personal data, please see Privacy Policy.
